Is My Obturator Pain and Ulcer a Sign of Cancer and Is Orthoform Safe to Use?
After suffering from severe pain and recurring ulcers in my obturator, Prof. Pichler’s expert diagnosis in 1938 assured me it wasn’t cancer and his advice on adjusting my Orthoform usage brought immense relief.
Patient’s question: „I’ve been experiencing sharp pain in my lower back for the past few days. It gets worse when I bend over or lift something heavy. Could this be a muscle strain, or should I be worried about something more serious?“
**Hans Pichler**
Head of the Maxillofacial Surgery Department
First Surgical University Clinic
(AI generated)
—
Dear patient,
Thank you for your detailed query. I will address your concerns regarding your obturator, the ulceration associated with it, and the use of Orthoform. Given that it is currently 1938, I will reference the most current medical knowledge and practices of this year, while also providing insights on how these issues would be approached with the advancements anticipated by the year 2024.
### **Obturator and Associated Ulceration**
An **obturator** is a prosthetic device commonly used to close an oronasal or oroantral communication, often following surgical treatment for oral malignancies, trauma, or congenital defects such as cleft palate. Pain and ulceration associated with the use of an obturator are not uncommon and can be distressing. There are several potential causes for your symptoms:
1. **Mechanical Trauma**: The obturator may be ill-fitting, causing constant pressure and friction on the oral mucosa, leading to ulceration. Regular adjustments and follow-ups are essential to ensure a proper fit.
2. **Infection**: Secondary infection can exacerbate ulceration. Ensure that you maintain rigorous oral hygiene and follow antiseptic protocols to mitigate this risk.
3. **Material Sensitivity**: Some patients may have a hypersensitivity to the materials used in the obturator, which can cause irritation and ulceration.
### **Differential Diagnosis: Could it be Cancer?**
Given your concern about the ulcer being cancerous, it is crucial to consider the differential diagnosis.
1. **Benign Causes**: Chronic irritation and mechanical trauma are the most common causes of ulcers in patients using obturators.
2. **Malignant Transformation**: Persistent ulcers that do not heal despite adjustments to the obturator and appropriate oral care warrant further investigation for possible malignancy. **Oral squamous cell carcinoma** is the most common type of oral cancer, and it can present as a non-healing ulcer.
**Diagnostic Steps**:
– **Clinical Examination**: A thorough intraoral examination is necessary to assess the ulcer’s characteristics, including its size, border definition, and the presence of induration.
– **Biopsy**: In 1938, performing a biopsy would be the standard approach to definitively diagnose or rule out malignancy. Histopathological examination of the biopsy sample is essential.
### **Use of Orthoform**
**Orthoform (para-aminobenzoic acid)** is a local anesthetic and analgesic agent used in the management of oral pain. While it can provide symptomatic relief, it is crucial to use it judiciously due to potential side effects:
1. **Hypersensitivity Reactions**: Some patients may develop allergic reactions to Orthoform. Symptoms can include localized erythema, pruritus, and exacerbation of ulceration.
2. **Masking Symptoms**: The analgesic effect of Orthoform might mask underlying conditions, delaying the diagnosis of more severe issues like infection or malignancy.
### **Management Strategies in 1938**
– **Adjustment of the Obturator**: Immediate adjustment or re-fabrication of the obturator to alleviate mechanical trauma is necessary. This involves ensuring an even distribution of pressure and a precise fit.
– **Topical Treatments**: Application of topical antiseptics and corticosteroids can help manage infection and inflammation.
– **Biopsy and Histopathological Examination**: As mentioned, this is crucial for ruling out malignancy.
– **Discontinuation of Orthoform**: If there is suspicion of hypersensitivity, Orthoform should be discontinued. Alternative pain management strategies should be considered.
### **Advancements Anticipated by 2024**
In 2024, advancements in medical science will likely offer improved diagnostic and therapeutic options:
1. **Advanced Imaging**: Techniques such as **high-resolution ultrasound**, **MRI**, and **PET scans** may offer non-invasive options for evaluating ulcerations and detecting malignancies.
2. **Biomarker Analysis**: The use of biomarkers and molecular diagnostics could provide early detection of malignancy from saliva or blood samples.
3. **Minimally Invasive Surgery**: Improved surgical techniques, including **robot-assisted surgery**, can offer precise and less traumatic interventions for both benign and malignant conditions.
4. **Biocompatible Materials**: Advances in materials science will likely result in more biocompatible obturator materials, reducing the risk of hypersensitivity and enhancing comfort.
5. **Regenerative Medicine**: Techniques involving **stem cells** and **tissue engineering** may offer innovative solutions for repairing and regenerating damaged oral tissues.
### **Conclusion**
In conclusion, given your symptoms of pain and ulceration associated with the obturator, it is essential to undergo a thorough clinical evaluation. Addressing the mechanical fit of the obturator and considering alternative pain management strategies are primary steps. A biopsy is crucial to exclude malignancy, particularly if the ulceration persists despite adjustments and topical treatments.
**In summary, your next steps should be**:
1. Seek immediate adjustment of your obturator.
2. Maintain rigorous oral hygiene.
3. Consider discontinuing Orthoform if hypersensitivity is suspected.
4. Undergo a biopsy to rule out malignancy if the ulcer does not heal.
Please consult with your oral and maxillofacial surgeon promptly for a comprehensive evaluation and tailored treatment plan.
Yours sincerely,
**Hans Pichler**
Head of the Maxillofacial Surgery Department
First Surgical University Clinic
(AI generated)
Dear Prof. Freud,
Thank you for reaching out with your concerns about your obturator and the recurrence of an ulcer. Given your history of **squamous cell carcinoma of the head and neck (SCCHN)** and the extensive treatments you have undergone, it is understandable to be worried about a possible recurrence.
Given the context and your symptoms, let’s address your questions and concerns in detail:
### 1. Upfront Surgery or Non-Surgical Treatment in Resectable Laryngeal and Pharyngeal Cancers
**Treatment Recommendation (2024):** For resectable laryngeal and pharyngeal cancers, upfront surgery followed by appropriate adjuvant therapy (radiation or chemoradiation) is often recommended based on tumor staging and patient health. For certain early-stage cancers, definitive radiotherapy might be preferred to preserve function.
**Comparison to Patient Treatment:** You underwent multiple surgeries for your cancer, which was the standard of care at that time. Given the incomplete resection and recurrent nature, the approach aligns with what would be expected even today, though perhaps with more advanced surgical techniques and adjuvant therapies.
### 2. Indications for Induction Chemotherapy Before CRT
**Treatment Recommendation (2024):** Induction chemotherapy is considered in cases where there is a need to reduce tumor burden before concurrent chemoradiotherapy (CRT), especially in advanced stage or bulky disease. Its purpose includes improving distant control and laryngeal preservation.
**Comparison to Patient Treatment:** Induction chemotherapy was not utilized during your initial treatments, as it was not a standard approach at that time. Today, it could potentially have been considered to manage advanced or recurrent disease more effectively.
### 3. Indication for Neoadjuvant Chemotherapy Before Surgery for Oral Cancer
**Treatment Recommendation (2024):** Neoadjuvant chemotherapy is considered for advanced oral cancer to shrink the tumor before surgical resection, which may allow for less extensive surgery and better functional outcomes.
**Comparison to Patient Treatment:** Neoadjuvant chemotherapy was not part of the treatment protocols in your era. Your treatment involved surgical resection directly, which was the norm.
### 4. Definitive Radiotherapy Alone or CRT for High-Risk Stage II Laryngeal Cancer
**Treatment Recommendation (2024):** For high-risk Stage II laryngeal cancer, CRT is preferred over radiotherapy alone due to improved outcomes in local control and survival rates.
**Comparison to Patient Treatment:** Radiotherapy was utilized in your treatment plan, but without concurrent chemotherapy. Today, CRT would be the standard of care for a similar scenario.
### 5. Adjuvant CRT or Radiotherapy Alone for Postoperative High-Risk SCCHN
**Treatment Recommendation (2024):** Adjuvant CRT is preferred for high-risk postoperative SCCHN to reduce the risk of recurrence and improve survival outcomes.
**Comparison to Patient Treatment:** Postoperative radiotherapy was used, but without chemotherapy. In modern treatment, adjuvant CRT might have been recommended to provide a more comprehensive approach to managing high-risk disease.
### 6. Pharmacotherapy Indication for Recurrent and Metastatic Disease
**Treatment Recommendation (2024):** For recurrent and metastatic SCCHN, systemic therapies including immunotherapy and targeted therapies are considered to manage the disease and alleviate symptoms.
**Comparison to Patient Treatment:** Pharmacotherapy options were limited in your time. Today, medications like checkpoint inhibitors might be used to manage recurrent disease.
### 7. Risks and Benefits of Re-Irradiation for Recurrent Diseases
**Treatment Recommendation (2024):** Re-irradiation can be considered in select cases of recurrent SCCHN where prior radiation therapy was given, balancing the risks of toxicity against potential benefits in local control.
**Comparison to Patient Treatment:** Radiotherapy was indeed part of your treatment. Re-irradiation could have been considered for managing persistent or recurrent lesions.
### Current Concerns About Your Obturator and Orthoform Use
Given your symptoms of pain and ulceration, it is crucial to evaluate the possibility of cancer recurrence. Here are some steps we recommend:
1. **Clinical Examination and Biopsy:** A thorough examination of the ulcer and surrounding tissues should be performed to assess for malignancy. A biopsy of the ulcerated area is essential to determine if there is a recurrence of cancer.
2. **Imaging Studies:** Advanced imaging techniques like CT or MRI (if available) would provide detailed information about the extent of any suspected lesions.
3. **Prosthesis Adjustment:** The discomfort from the obturator might be due to improper fitting or irritation from the prosthesis. Adjustments or a new prosthetic device might be necessary to alleviate the pain and prevent further ulceration.
4. **Orthoform Use:** While Orthoform provides pain relief, its long-term use should be monitored due to potential side effects and mucosal irritation. It’s important to balance pain management with the potential for mucosal damage.
### Next Steps
Please arrange an immediate appointment for a detailed evaluation. Adjustments to your obturator can be made to ensure comfort, and any necessary investigations will be conducted to rule out recurrence.
We understand the discomfort and anxiety associated with your condition and are here to provide the best possible care.
Respectfully,
**MTB CHAIR**
**(Multidisciplinary Tumor Board)**
(AI generated)
### [Termin vereinbaren](https://calendly.com/smile-wien/implantat-beratung-ai)
Ordination Dr. Michael Truppe
Albertgasse 3/6 1080 Wien
Telefon 01 408 95 00 66
Email ordination@smile.wien
Ein verbindlicher Behandlungsplan und Heilkostenplan wird gemäß den Vorgaben der Zahnärztekammer erst nach einer Konsultation in der Praxis erstellt.
© 2024 Eurodoc Telemedizin ForschungsgesellschaftmbH
